-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ISB-1302 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ISB-1302 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ISB-1302 in...
-
Product Insights
NewOptic Neuropathy – Drugs In Development, 2024
Empower your strategies with our Optic Neuropathy – Drugs In Development, 2024 report and make more profitable business decisions. Optic neuropathy is an inherited form of vision loss. Symptoms include eye pain or discomfort, numbness, tingling, and clouding of vision. Predisposing factors include age, smoking, alcohol, cancer treating drugs, stress related chemicals, some antibiotics, and cyanogens. The Optic Neuropathy drugs in development market research report provide comprehensive information on the therapeutics under development for Optic Neuropathy, complete with analysis by stage...
-
Product Insights
NewGlaucoma – Drugs In Development, 2024
Empower your strategies with our Glaucoma – Drugs In Development, 2024 report and make more profitable business decisions. Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow to the optic nerve. The most important risk factors include age, elevated eye pressure, African ancestry, thin cornea, and family history of glaucoma. Signs and symptoms include...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Omalizumab Biosimilar in Allergic Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Omalizumab Biosimilar in Allergic Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Omalizumab biosimilar in Allergic Asthma Drug Details: Omalizumab biosimilar (GBR-310)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ISB-1342 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ISB-1342 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ISB-1342 in Solid Tumor Drug Details:ISB-1342 (GBR-1342) is under development for the treatment...
-
Product Insights
Bone Growth Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Bone Growth Stimulators Pipeline Market Report Overview Bone growth stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures or fusions. They apply electrical or ultrasound waves to the site of the fracture or fusion. The bone growth stimulators pipeline market research report provides comprehensive information about the bone growth stimulators pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key...
-
Product Insights
DoT Louisiana – MRB South GBR: LA 1 to LA 30 Connector – Louisiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our DoT Louisiana - MRB South GBR: LA 1 to LA 30 Connector - Louisiana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Hausverwaltung GbR/ ROCKSTONE RE – Schöneberger Eck High-Rise Building Development – Berlin
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hausverwaltung GbR/ ROCKSTONE RE – Schöneberger Eck High-Rise Building Development – Berlin report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough...
-
Sector Analysis
Eastern Europe Meat Substitutes Market Size, Competitive Landscape, Country Analysis, Distribution Channel, Packaging Formats and Forecast, 2021-2026
Eastern Europe Meat Substitutes Market Overview The Eastern Europe meat substitutes market size was valued at $7.10 billion in 2021 and the market is expected to achieve a CAGR of more than 11% during 2021-2026. Based on the relative performance of countries on multiple metrics, Poland, Slovakia, Romania, and Hungary were shortlisted as high-potential countries due to large market size, projected high-value growth rates, and projected rising per capita value growth levels. The Eastern Europe meat substitutes market research report brings...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – omalizumab biosimilar
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry omalizumab biosimilar Drug Details Omalizumab biosimilar (GBR-310) is under development for the treatment of...